Health
Mesoblast receives $138m injection from US investors
Australian biotechnology company Mesoblast (ASX: MSB) will receiv...
Investors like what they see under Healthia's skin, boosting its value to $185m
Allied health company Healthia Limited (ASX: HLA) has almost doub...
Needle-phobes rejoice: NeedleCalm launches in Australia
An innovative piece of medical technology aimed at reducing physi...
Medibank profit rises, CEO Craig Drummond to depart
Private health insurance provider Medibank (ASX: MPL) has capital...
Starpharma's anti-COVID nasal spray approved in Europe and the UK
Australian pharmaceutical company Starpharma's (ASX: SPL) ant...
Advertisement
Latest News
Employment Hero soaring overseas on $45m raise
Sydney-based human resources platform Employment Hero is looking ...
US software company buys Sensis from Telstra for $250m
The operator of the Yellow and White Pages, True Local and Wheris...
Chinese investment in Australia hits six-year low
New data from the Australian National University (ANU) shows Chin...
Whispir bags $45m for international expansion
A $45 million placement, completed today, will see cloud computin...
Mesoblast receives $138m injection from US investors
Australian biotechnology company Mesoblast (ASX: MSB) will receiv...
Ecofibre signs "milestone" international distribution deal for CBD products
A new deal between Ecofibre (ASX: EOF) and Sydney-based pharmaceu...
Smiles Inclusive CEO resigns as Genesis Capital wins bid to acquire assets
After 10 months at the helm of embattled Gold Coast-based dental ...
Pro Medicus pens $40m contract with Utah's largest healthcare provider
Health imaging company Pro Medicus (ASX: PME) has today announced...
Noxopharm COVID-19 treatment trial advances to the final stage
A trial of medtech Noxopharm's (ASX: NOX) COVID-19 treatment ...
Skin repair med-tech PolyNovo notches sales growth despite COVID hurdles
Medical technology company PolyNovo (ASX: PNV) recorded 31 per ce...
Mesoblast shares crash as COVID treatment fails the test
Shares in Melbourne-based biotech Mesoblast (ASX: MSB) almost hal...
Ellume strikes gold in US as FDA approves rapid COVID-19 test
Brisbane Young Entrepreneur of the Year Dr Sean Parsons has achie...
Cannabis companies celebrate TGA green light for over the counter sales
Australian medicinal cannabis companies have praised the Therapeu...
CSL steps up AstraZeneca production after abandoning its own COVID-19 vaccine
The federal government is stepping up production of the AstraZenc...
CSL shares slip after dumping plans for new COVID-19 vaccine
Australia's largest biotechnology company CSL (ASX: CSL) has ...
Starpharma surges as COVID nasal spray wafts into Europe
Shares in Starpharma (ASX: SPL) surged more than 17 per cent in m...
Former PM Turnbull backs $18m HealthMatch raise
HealthMatch, a clinical trial matching platform, has raised $18 m...
Australian Natural Therapeutics Group receives cannabis oil manufacturing license
NSW-based Australian Natural Therapeutics Group (ANTG) has been g...
Cannabis stocks get a healthy boost after UN removes narcotic tag
Shares in Australian cannabinoid-based medicine producers were g...
Aussies to wait for now as UK starts rolling out Pfizer vaccine
The UK may be ready to roll out the new Pfizer-BioNTech COVID-19 ...
Advertisement
Partner Content
It took determination and ambition for Glen Richards to scale up ...
It's fair to say that at the start of 2020, few would have pr...
Momentum for cannabis stocks continues to intensify, as internati...
ESG (Environment, Social, Governance) has become essential in bus...
While some prefer to invest their money in stocks, bonds or prope...
If intellectual property (IP) is what differentiates a business f...
The COVID-19 pandemic has fundamentally changed the way Australia...
Curtin University and Extreme Tech Challenge (XTC) have partnere...
Due diligence is paramount for responsible lending, but that does...
After seeing how expensive and time-consuming it was for the mili...
Advertisement